Neuronetics

Yahoo Finance • 25 days ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroh... Full story

Yahoo Finance • 2 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story

Yahoo Finance • 2 months ago

Canaccord Genuity lowers Neuronetics stock price target on margin concerns

Investing.com - Canaccord Genuity lowered its price target on Neuronetics (NASDAQ:STIM) to $7.00 from $8.00 on Wednesday, while maintaining a Buy rating on the stock. The medical device company, with a market capitalization of $300 milli... Full story

Yahoo Finance • 2 months ago

Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises

Earnings Call Insights: Neuronetics (STIM) Q2 2025 MANAGEMENT VIEW * CEO Keith Sullivan highlighted a strong second quarter, stating, “We had a strong second quarter at Neuronetics, both in terms of our ability to drive accelerated top... Full story

Yahoo Finance • 2 months ago

Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss

Neuronetics Inc (NASDAQ:STIM [https://www.chartmill.com/stock/quote/STIM/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. While revenue exceeded estimates, the com... Full story

Yahoo Finance • 2 months ago

Neuronetics GAAP EPS of -$0.15 misses by $0.07, revenue of $38.11M beats by $1.17M

* Neuronetics press release [https://seekingalpha.com/pr/20188747-neuronetics-reports-second-quarter-2025-financial-and-operating-results] (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]): Q2 GAAP EPS of -$0.15 misses by $0.07. * R... Full story

Yahoo Finance • 2 months ago

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth Generated record Greenbrook clinic revenue of $23.0 million in the quarter Reduced cash used in operations to $3.5 million, beating... Full story

Yahoo Finance • 2 months ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever... Full story

Yahoo Finance • 2 months ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 3 months ago

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 3 months ago

Neuronetics Appoints New Chief Financial Officer

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process Neuronetics reiterates g... Full story

Yahoo Finance • 3 months ago

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS Society/CTMSS Meeting and provided an update on Gr... Full story

Yahoo Finance • 4 months ago

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever... Full story

Yahoo Finance • 4 months ago

Neuronetics to join Russell 3000 and Russell 2000 indexes

* Neuronetics (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]) will be added to the Russell 3000 and Russell 2000 Indexes after market close on June 30, 2025. * STIM shares rise 5% post-market on Monday. * Source: Press release [... Full story

Yahoo Finance • 4 months ago

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients wheneve... Full story

Yahoo Finance • 5 months ago

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a... Full story

Yahoo Finance • 5 months ago

Neuronetics Reports First Quarter 2025 Financial and Operating Results

MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transformin... Full story

Yahoo Finance • 6 months ago

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients wheneve... Full story

Yahoo Finance • 7 months ago

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press release to update the reporting of its financial results for the fourth quarter and full year ending... Full story

Yahoo Finance • 7 months ago

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transformi... Full story